Global Gingivitis Treatment Industry on Track to Reach US$ 11.19 Billion by 2033 with a Noteworthy 4.8% CAGR | FMI

Global Gingivitis Treatment Industry

The Global Gingivitis Treatment Industry, currently valued at US$ 7 Billion, is poised for remarkable growth, anticipated to reach US$ 11.19 Billion by the year 2033. This substantial advancement is expected to unfold at a steady Compound Annual Growth Rate (CAGR) of 4.8% between 2023 and 2033.

As health-conscious consumers increasingly recognize the integral connection between overall health and oral well-being, the demand for oral care services and products has witnessed a significant upswing. The rise in awareness has led to a surge in the Gingivitis Treatment Market, fueled by an ever-growing population seeking effective solutions to maintain optimal oral health.

One of the driving forces behind this growth is the burgeoning number of online sales channels, providing consumers with convenient access to a wide range of gingivitis treatment options. This trend has not only expanded the market reach but has also contributed to the market’s overall expansion, providing consumers with a seamless experience in procuring oral care products.

Request a Sample of this Report Now!

Gingivitis causes bleeding and inflammation of gums. Moreover, if not treated on time, it could progress to all the more severe form of gum disease. The WHO states that gingivitis affects close to 90% of the population worldwide.

Poor oral hygiene, aging, smoking, chewing of tobacco result in gingivitis. However, the good part is that awareness in this regard is rising. As such, apart from drugs, lasers are getting used for treating the disease. This factor is expected to enhance the popularity of gingivitis treatment market going forward.

At the same time, the fact that gingivitis treatment is costly could hamper the gingivitis treatment market going forward. Also, compliance to regulations in this regard is challenging. So, small companies may have to think twice before venturing herein.

Future Market Insights has entailed these facts with future prospects in its latest market study entitled ‘Gingivitis Treatment Market’. It has its team of analysts and consultants to execute using an eagle’s eye view in its primary, secondary, and tertiary modes of research.

“With growing awareness regarding oral hygiene, the global gingivitis treatment market is expected to go great guns in the forecast period”, says an analyst from Future Market Insights.

Ask Us Your Questions About This Report

Competitive Treatment

  • It was announced in October 2022 that rapid test regarding gum disease was being developed at the University of Birmingham. The basic purpose of this probe is that of being used in point-of-care settings like dental pharmacies or surgeries. It could also help in detection of lung or heart disease at an early stage, along with rheumatoid arthritis and type 2 diabetes. On these grounds, Professor Tim Albrecht from School of Chemistry and Dr. Melissa Grant from the School of Dentistry at the University have developed a unique technique of precise assessment of gum disease using sample of saliva.
  • The other players in gingivitis treatment market include Fibrocell Sciences, Eli Lilly & Company, Dentsply International, Align technology, Ultradent Products Inc., 3M Company, Glidewell Laboratories, Nobel Biocare Holdings AG, Kaken Pharmaceutical, Orapharma, and Valeant Pharmaceuticals Inc. They are engaging in various modes of expansion like new product launch, mergers, acquisitions, partnerships, and joint ventures to make a mark for themselves in gingivitis treatment market.

What does the Report say?

  • The research study is based on drug class (veetids, erythrocin, minocycline, doxycycline, clindamycin, chlorhexidine, acetaminophen, ibuprofen, and lidocaine), route of administration (oral and topical), and end-user (hospital pharmacy, retail pharmacy, and online pharmacy).
  • With growing prevalence of gum disease, the global gingivitis treatment market is expected to grow irresistibly in the forecast period.

Request Your Customized Report Now!

Key Companies Profiled:

Fibrocell Sciences, Tolmar Inc., Eli Lilly & Company, Align Technology, Dentsply International, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Orapharma, Kaken Pharmaceutical, and Valeant Pharmaceuticals Int.

Key Segments Profiled in the Gingivitis Treatment Industry Survey

Drug Class:

  • Veetids
  • Erythrocin
  • Minocycline
  • Doxycycline
  • Clindamycin
  • Chlorhexidine
  • Acetaminophen
  • Ibuprofen
  • Lidocaine

Route of Administration:

  • Oral
  • Topical

Click Here To Buy Your Full Report


  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy


  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa


Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these